Dipropizine clinical trials
Also written Levodropropizine.
How each study uses dipropizine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the dipropizine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
6 studies that test it; most in 2025 (2)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 1
Pontificia Universidad Catolica de Chile (1) · Dompé Farmaceutici S.p.A (1) · Hyundai Pharm (1) · Hanmi Pharmaceutical Company Limited (1) · Pharmbio Korea Co., Ltd. (1) · Ache Laboratorios Farmaceuticos S.A. (1)
Often tested with
Tested in the same studies.
Codeine (1) · Ambroxol (1) · Diphenhydramine (1) · Pseudoephedrine (1)
Studies
Open first, then newest update. How each study uses dipropizine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- Evaluation of the Pharmacokinetics of "PBK_M2301" in Healthy AdultsRecruitingPhase 1Pharmbio Korea Co., Ltd.NCT07161180Written as R1_PBK_M2301 (levodropropizine)
- CHAO Tos: Codeina, HederA Helix, LevOdropropizina Para la TOSCompletedPhase 4Pontificia Universidad Catolica de ChileNCT06907355Written as Levodropropizine
- Clinical Trial of Efficacy and Safety of Levopront® 30 mg/5 ml in Patients With Dry CoughCompletedPhase 3Dompé Farmaceutici S.p.ANCT03837938Written as Levopront® syrup 30 mg/5 ml
- Phase III Study to Evaluate the Efficacy and Safety of HOB-048 CR Tab. in Comparison With HOB-048 Syrup in Patients With Cough Due to Acute or Chronic BronchitisCompletedPhase 3Hyundai PharmNCT03489837Written as Levotuss
- Evaluation of Efficacy and Safety in Control Cough and the Relief of Nasal Symptoms in Children 2-12 Years Old,Suffering From Cough and Acute RhinitisWithdrawnPhase 3Ache Laboratorios Farmaceuticos S.A.NCT01177852Written as diphenhydramine + dropropizine + pseudoephedrine
- A Drug-Drug Interaction Study of Ambroxol and LevodropropizineCompletedPhase 1Hanmi Pharmaceutical Company LimitedNCT01573663Written as Ambroxol and Levodropropizine
Given beside what is tested · 1 — dipropizine is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with dipropizine
Codes
What other systems call dipropizine · ClinicalTrials.gg INT003057
- MeSH (NLM) C035916dipropizineConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 3O31P6T4G3LEVODROPROPIZINEConfirmed FDA, NLM
- RxNorm 52014One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C035916 | dipropizine | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 3O31P6T4G3 | LEVODROPROPIZINE | Confirmed FDA, NLM |
| RxNorm | 52014 | — | One source FDA |
Also registered as dropropizine (UNII U0K8WHL37U · RxNorm 23419).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.